SG Americas Securities LLC Takes $462,000 Position in Phreesia, Inc. (NYSE:PHR)

SG Americas Securities LLC bought a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 18,069 shares of the company's stock, valued at approximately $462,000.

A number of other hedge funds have also made changes to their positions in PHR. Deerfield Management Company L.P. Series C lifted its holdings in shares of Phreesia by 133.6% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company's stock valued at $31,999,000 after buying an additional 727,384 shares during the last quarter. Greenhouse Funds LLLP raised its position in Phreesia by 27.9% during the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after acquiring an additional 626,579 shares in the last quarter. Park West Asset Management LLC acquired a new stake in Phreesia in the fourth quarter valued at approximately $10,657,000. Millennium Management LLC grew its position in Phreesia by 83.2% in the fourth quarter. Millennium Management LLC now owns 653,634 shares of the company's stock worth $16,445,000 after acquiring an additional 296,863 shares in the last quarter. Finally, ExodusPoint Capital Management LP increased its stake in shares of Phreesia by 448.6% during the 4th quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company's stock worth $4,402,000 after purchasing an additional 143,077 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Phreesia news, insider Yvonne Hui sold 1,878 shares of the stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $44,790.30. Following the sale, the insider now owns 28,449 shares of the company's stock, valued at $678,508.65. This represents a 6.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP David Linetsky sold 3,944 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $94,064.40. Following the completion of the sale, the senior vice president now owns 221,738 shares of the company's stock, valued at $5,288,451.30. The trade was a 1.75% decrease in their position. The disclosure for this sale can be found here. Insiders sold 47,803 shares of company stock worth $1,178,537 in the last quarter. 5.50% of the stock is owned by corporate insiders.

Phreesia Price Performance

Shares of PHR stock traded up $0.50 during trading hours on Friday, hitting $28.45. The company had a trading volume of 2,170,775 shares, compared to its average volume of 509,019. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of -38.45 and a beta of 0.68. The firm's fifty day moving average is $25.45 and its 200 day moving average is $26.07. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business's revenue was up 14.5% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.05) earnings per share. On average, sell-side analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Truist Financial lifted their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. DA Davidson reduced their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Canaccord Genuity Group lowered their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research report on Thursday, May 29th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Finally, KeyCorp cut their price target on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $31.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.